AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Debate on Weight Loss Drug Prices and Healthcare System Issues
This chapter explores the controversy surrounding the steep costs of weight loss medications like Ozempic and Wigovi, featuring testimony from the CEO of Novo Nordisk. It highlights public frustration over pharmaceutical profits and the implications for the U.S. healthcare system.